Latest
All News
Reports
Events
Directory
Contact
More
Variant Bio and Novo Nordisk sign multi-year research partnership to discover novel targets for metabolic disease
Journal Watch 8/1/2024
Biomea Fusion announces first data on icovamenib-semaglutide combination study
MBX Biosciences announces positive phase 1 topline results for MBX 1416 for the treatment of PBH
